Page results
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Information about the integrated rheumatology service at the Royal London Hospital for Integrated Medicine.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
File results
-
FOI/2021/2021 - Number of deaths registered for measles
-
FOI/2021/0643 - Bank and agency staffing vacancy rates and spending
-
FOI/2021/0644 - Clinical guidelines on identification and management of maternity issues
-
FOI/2021/0645 - Software suppliers for various applications
-
FOI/2021/0649 - Physiotherapists/ occupational therapists staffing levels
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations